Maryland-based supply chain solutions provider Movilitas has announced that the Alter Pharma Group, a Belgian pharmaceutical group active in the distribution of pharmaceutical products to pharmacies, wholesalers, hospitals and retirement homes and in the development and licensing of generic drugs, adopted its Movilitas.Cloud software as a service solution to meet the many requirements in the (re)packaging process that are specified under the EU FMD regulation, while also benefiting from improved operational efficiencies throughout the product path and changes in packaging.
Medicine
Under the EU FMD directive, repackagers and parallel distributors have unique responsibilities. Their medicinal product is often bought from regulated wholesalers and then medicine authenticity and product serial numbers must be verified and managed from geographically separated processing plants through the point of distribution.
"By leveraging Movilitas.Cloud technology, we now have a state-of-the-art system that provides transparency and ensures the integrity of our products as they move across the supply chain," said Stijn Vlaminck, IT Manager of the Alter Pharma Group. "The solution provides a single system to manage and track each pack in order to remain compliant with EU FMD regulations and deliver on the highest standard of quality and safety."
Movilitas.Cloud offers a set of services to maintain product integrity during changes in packaging:
- Supports the complete receiving and verification process of original medicines
- Sends automatic decommissioning requests containing all serial numbers grouped into SSCCs
- Sends commissioning requests of the repacked products
- Manages serial numbers between EU-Hub through QA functionality
- Supports manual, semi-automatic and automatic processes
"We are pioneering an efficient way of managing the reporting of serial numbers during the repackaging process," said Marc Blekkink, global head of business development for Movilitas.Cloud. "We're committed to delivering IoT solutions that enable repackagers and parallel importers to deliver safe medicinal products while remaining compliant."
Back to Homepage
Back to Healthcare
Back to Technology & Innovation